Jul 06, 2020
Mylan Secures Regulatory Approval for Remdesivir Lyophilized Powder for Injection 100 mg/vial in India for Restricted Emergency Use in COVID-19 Patients
Jun 03, 2020
Howard Rosen Joins twoXAR Pharmaceuticals' Board of Directors
May 14, 2020
Evox Therapeutics Appoints Paul Carter as Non-executive Chairman
May 13, 2020
Hetero Enters Into a Licensing Agreement With Gilead Sciences, Inc. for the Manufacturing and Distribution of "Remdesivir" in 127 Countries, Including India, for COVID-19
May 12, 2020
Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19
Apr 27, 2020
Global Diabetic Nephropathy Pipeline Assessment, H1 2020: Therapeutics, Developments, Products, Drugs, Players
Apr 23, 2020
Scientists Worldwide Feverishly Working to Develop New Drug and Vaccine Candidates for COVID-19 Crisis
Apr 22, 2020
Global Human Papillomavirus (HPV) Associated Cancer Pipeline Guide, H1 2020: Therapeutics, Drugs, Products, Players, Projects
Apr 17, 2020
CAR T-Cell Therapy for Non-Hodgkin's Lymphoma | US & EU Market Sizes from 2017 to 2030, Details of Marketed & Emerging Therapies Kymriah (Novartis) & KTE-X19 (Gilead Sciences)
Apr 06, 2020
Coronavirus (COVID-19) Drug Pipeline Insights, 2020 - The COVID-19 Pipeline Remains Robust with 30+ Therapeutic Candidates Under Development
Mar 23, 2020
Biotechs and Big Pharma in a Race Against Time Battling Global Health Crisis
Mar 19, 2020
FDA Approves New Treatment for Pediatric Patients with Any Strain of Hepatitis C
Mar 18, 2020
Exploring Avenues in Personalized Medical Care Defines Advances in Red Biotechnology Market: Valuation to Touch Massive US$512 Bn By 2027, Finds Transparency Market Research
Feb 27, 2020
Antiviral Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Application, By Type, By Region And Segment Forecasts, 2020 - 2027
Feb 26, 2020
Global Antiviral Drugs Industry Insights, 2016-2019 & 2020-2027 - HIV Applications to Witness the Fastest Growth
Feb 06, 2020
Sierra Oncology Completes Conversion of Preferred to Common Stock and Issues Stock to Gilead
Jan 30, 2020
Global Gene Therapy Industry Outlook 2020-2024 - Strong Product Pipeline Gives Rise to Lucrative Growth Opportunities
Jan 30, 2020
The global gene therapy market is projected to reach USD 13.0 billion by 2024 from USD 3.8 billion in 2019, at a CAGR of 27.8%
Jan 30, 2020
Cardiovascular Drugs Market Value Garner US$ 92.3 Bn by 2026
Jan 24, 2020
Non-Alcoholic Steatohepatitis (NASH) H1, 2020: Pipeline Landscape; Therapeutics Development & Assessment, Drug Profiles, Dormant Projects, Discontinued Products